Others: GPC3 knockdown in ovarian cancer cells can lead to an increase in the expression of matrix metalloproteinase 2 (MMP-2) and MMP-9, along with a decrease in the level of tissue inhibitors of metalloproteinase 1 (TIMP-1) [103]. Here, GPC3 is linked to ovarian carcinoma.